Exchange: NASDAQ·Updated 07:30 PM EDT
News
all
press releases
Full Transcript: Sensus Healthcare Q2 2026 Earnings Call
Sensus Healthcare (NASDAQ:SRTS) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensiveread more...
Benzinga
More News
Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended June 30, 2026. Highlights...
Business Wire
Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the company will report financial results for the second quarter of 2026 on Thursday, August 13...
Business Wire
Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended March 31, 2026. Highlights...
Business Wire
Sensus Healthcare (SRTS) Projected to Post Earnings on Thursday
Sensus Healthcare (NASDAQ:SRTS) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...
MarketBeat
Sensus Healthcare (NASDAQ:SRTS) Shares Pass Below 50-Day Moving Average - Here's Why
Sensus Healthcare (NASDAQ:SRTS) Stock Passes Below Fifty Day Moving Average - Time to Sell...
MarketBeat
Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced...
Business Wire
Sensus Healthcare, Inc. (NASDAQ:SRTS) Receives Average Rating of "Moderate Buy" from Analysts
Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six ratings firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned...
MarketBeat
Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update
Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) saw a large decrease in short interest in March. As of March 13th, there was short interest totaling 394,950 shares, a decrease of 18.3% from the February 26th total of 483,655 shares. Currently, 2.6% of the company's shares are sold short...
MarketBeat
Sensus Healthcare, Inc. (NASDAQ:SRTS) Given Consensus Rating of "Moderate Buy" by Analysts
Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) have been given an average rating of "Moderate Buy" by the six analysts that are currently covering the firm, MarketBeat.com reports...
MarketBeat

Advertisement|Remove ads.